Skip to main content
. 2021 Dec 1;10(12):1477. doi: 10.3390/antibiotics10121477

Figure 3.

Figure 3

Probability of progression to non-invasive ventilation according to Bayesian classifier (NBC). Patients treated with Remdesivir hospitalized during the second COVID-19 wave (March 2021–September 2021—Group B).